Transgene Biotek Auditor Resignation Signals Governance Uncertainty

Resignation effective October 28, 2026; company loses second auditor in 18 days.

Reader Takeaway: Repeated auditor turnover in under one month raises serious concerns regarding corporate governance and financial reporting stability.

What just happened

Transgene Biotek Ltd has disclosed that its statutory auditor, M/s. Eswara Rao & Co., has resigned from their position with immediate effect. The auditor, who was appointed on October 10, 2026, to fill a casual vacancy, left the role on October 28, 2026, citing pre-occupation with other assignments. The auditor confirmed that no audit or limited review work had been initiated prior to their resignation and stated there were no disagreements or lack of cooperation from management.

Why this matters

The departure of two separate audit firms within a single month is highly irregular. Statutory auditors play a crucial role in verifying financial integrity; multiple resignations in such a short window often indicate underlying issues within a company's internal controls or management-auditor relationships. Investors typically view high turnover among key fiduciaries as a major red flag regarding the company's governance standards.

The backstory

This resignation follows the earlier departure of M/s. Vasavi & Co. M/s. Eswara Rao & Co. had been brought in specifically to fill that vacancy, yet they lasted less than three weeks. These consecutive departures suggest a broader instability in the company’s corporate administration.

Risks to watch

Beyond the immediate operational delay in conducting quarterly financial reviews, the company faces the risk of increased scrutiny from regulatory bodies. Market confidence is likely to be impacted, as shareholders will now be waiting for the next auditor appointment to see if the firm can find a permanent solution to its reporting requirements.

What to track next

Shareholders should prioritize tracking upcoming BSE filings for the announcement of a new auditor. Any further delays in filing audited results or further auditor churn will be critical indicators of the depth of the company's internal instability.